DOC:NYSEHealthpeak Properties, Inc. Analysis

Healthpeak Properties, Inc. (DOC) is trading at $19.49, comfortably above its 20‑day SMA of 17.78 and the 50‑day SMA of 17.29, yet still below the calculated resistance of 19.91, suggesting limited upside in the immediate term. The stock’s RSI of 71 and a bullish MACD histogram (+0.21) signal overbought momentum, while volume trends are increasing, reinforcing short‑term buying pressure. However, the REIT carries a pronounced leverage profile (debt‑to‑equity ≈ 118×) and an extreme forward P/E of 144.37, which together elevate valuation risk despite a solid dividend yield of 6.26% and a payout ratio above 3× earnings. Over the medium horizon, the company’s stable FFO generation (DCF fair value ≈ $14.43) and a price‑to‑FFO proxy of 10.89 align with a modest upside toward the consensus target median of $20, though the high beta (0.68) and a max drawdown of –18.5% temper confidence. In the long run, the REIT’s exposure to U.S. healthcare tenant credit cycles (geographic risk = low) and regulatory changes (regulatory risk = medium) are balanced by a resilient cash‑flow profile, but the combination of high debt, low ROE (2.8 %) and a forward‑looking P/E that dwarfs earnings suggest a medium overall risk score of 5.